"We look forward to marketing InnerCool's products in Italy and are pleased to offer a comprehensive portfolio of temperature modulation systems to Italy's physicians and healthcare providers in this growing therapeutic market," stated Paolo Cremascoli, Chief Executive Officer of N.G.C. Medical. "The InnerCool product line is a good fit for our team since key clinicians and areas of the hospital where we focus are utilizing temperature modulation products and therapies."
InnerCool's Surface and Endovascular Temperature Modulation Systems
InnerCool's new CoolBlue(TM) surface temperature modulation system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a tool for use in less acute patients or in clinical settings best suited to prolonged temperature management. InnerCool's CoolBlue vest and thigh pads wrap the body without requiring any adhesives to stick to the skin and produce cooling rates of around 1 degree Celsius per hour, i.e. similar to those of currently-marketed surface cooling systems and endovascular systems using inflatable balloon-based catheters. InnerCool's CoolBlue external or surface-based temperature modulation system is designed to cool or warm patients from outside of their bodies and is intended for use in less acute settings such as in-hospital fever management.
InnerCool's endovascular approach to patient temperature modulation is
based on a single-use flexible metallic catheter and a fully-integrated
cooling system, which allows for rapid and controlled cooling and
re-warming. InnerCool's endovascular system integrates a number of
desirable features including a slim catheter profile, a highly efficient
flexible metallic thermal transfer element, a built-in temperature
monitoring sensor, and a programmable console capable of rapidly and
controllably inducing, maintaining and reversing therapeutic cooling.
InnerCool's endovascular cat
|SOURCE Cardium Therapeutics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved